Your session is about to expire
← Back to Search
Platelet rich plasma for Erectile Dysfunction
Phase 3
Waitlist Available
Led By Chris Deibert, MD, MPH
Research Sponsored by University of Nebraska
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* history of mild to moderate erectile dysfunction measured by IIEF
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 1, 3 and 6 months
Awards & highlights
Pivotal Trial
Summary
This trial is testing whether injecting a concentrated solution of a man's own blood into his penis can help improve erectile function. The study focuses on men aged 50-80 who have erectile dysfunction. This solution is thought to work by using growth factors in the blood to heal and improve tissue health.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at 1, 3 and 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 1, 3 and 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Erectile Function Change
Other study objectives
Side Effects
Awards & Highlights
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Platelet rich plasmaExperimental Treatment1 Intervention
All arms will have phlebotomy (blood drawn). This group will receive PRP injection only.
Group II: PlaceboPlacebo Group1 Intervention
All arms will have phlebotomy (blood drawn). This group will receive saline injection only.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Platelet rich plasma
2010
Completed Phase 4
~1300
Find a Location
Who is running the clinical trial?
University of NebraskaLead Sponsor
554 Previous Clinical Trials
1,145,388 Total Patients Enrolled
Chris Deibert, MD, MPHPrincipal InvestigatorUniversity of Nebraska
Chris Deibert, MD, MPJHPrincipal InvestigatorUniversity of Nebraska
Share this study with friends
Copy Link
Messenger